LDS/Medical Tests/Acetylcholinesterase (AChE), Amniotic Fluid

Acetylcholinesterase (AChE), Amniotic Fluid

Cholinesterases are the enzymes that hydrolyze the neurotransmitter acetylcholine, into acetate and choline. There are two distinct type of the cholinesterases; acetylcholinesterase (‘true cholinesterase’) and acylcholine acylhydrolase (pseudocholinesterase). Acetylcholinesterase (AChE) is found in erythrocytes, lungs, spleen, nerve endings and the gray matter of the brain. In the erythrocytes, it is anchored to the external surface of the cell membrane and its appearance is diminished in Paroxysmal Nocturnal Hemoglobinuria (PNH). Pseudocholinesterases are found in the liver, pancreas, heart, white matter of brain and serum. Organophosphate insecticides inhibit both red cell AChE and plasma cholinesterase by binding to their active sites. Therefore, measurement of AChE can be done to assess patients for organophosphate exposure. As the half-life of plasma cholinesterase is about 8 days, it can be used to assess for recent exposure. Conversely, the half-life of RBC AChE is over 3 months, therefore it can be used to evaluate long-term exposure to organophosphate poisons.

Decreases in the plasma cholinesterase activity may also be seen when there is impaired synthesis of the enzymes by the liver. Therefore, the measurement of plasma cholinesterase can also serve as a marker to assess the synthetic function of the liver. Plasma cholinesterase measurement can also be used to identify patients with inherited abnormal cholinesterase variants as a preoperative screen for the patients who may receive succinyldicholine or mivacurium drugs as muscle relaxants during anesthesia.

Analysis of AChE along with alpha-fetoprotein in amniotic fluid is useful in the screening for fetal neural tube defects (NTDs). AChE is found in small concentration in fetal serum, but normal amniotic fluid does not contain AChE. The presence of AChE in the amniotic fluid is consistent with an open NTD allowing AChE from the cerebrospinal fluid to enter the amniotic fluid.

  • Use as an indicator of organophosphate poisoning including many pesticides
  • Screening patients for AChE variants prior to anesthesia
  • As an aid in diagnosis of neural tube defects

RBC AChE

Decreased in:

  • Organophosphate exposure
  • Paroxysmal Nocturnal Hemoglobinuria

Amniotic fluid AChE

Positive (Detected) in:

  • Open neural tube defect
  • Ventral wall defect

Negative

Qualitative Gel Electrophoresis, Radial Immunodiffusion.

Amniotic fluid:

Avoid contamination with blood

Stability

  • Ambient: 2 months
  • Refrigerated: 4 months
  • Frozen: 3 years
Alpha-fetoprotein (AFP), Serum cholinesterase.
3-7 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Clin Chim Acta. 1995;237:91-105. [PMID: 7664482]
  • Am Fam Physician. 1993;47:1613-20. [PMID: 8503347]
  • Rev Environ Contam Toxicol. 2000;163:29-111. [PMID: 10771584]
  • J Obstet Gynaecol Can. 2014;36:927-939. [PMID: 25375307]
  • Panteghini M, Bais R. Serum Enzyme. Textbook of Clinical Chemistry and Molecular Diagnostics. 5th ed. 2012. Page 565-98
  • Dear JW. Poisoning. Clinical Biochemistry metabolic and clinical aspects. 3rd ed. 2014. Page 787-807